Zurnai Injection, Solution
Product Images NDC 59011-962

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Zurnai (NDC 59011-962). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Knoa Pharma Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Nalmefene 01)

FDA Label Image

Figure 1 (Nalmefene 02)

Figure 1 (Nalmefene 02)
This is a description of minute ventilation (measured in L/min) before and after the administration of ZURNAI 1.5 mg IM. The graph shows the baseline minute ventilation, the lowest point (nadir), and the minute ventilation after the administration of ZURNAI over a 30-minute time period.*
FDA Label Image

Figure 2 (Nalmefene 03)

Figure 2 (Nalmefene 03)
This text appears to be a label or description related to a product or medication called "ZURNAI 1.5 mg." It seems to include a graph or data related to time (in minutes) and dosages. The text also mentions "Sulfasegd Jo Juadiad" but the context is unclear.*
FDA Label Image

Figure 3 (Nalmefene 04)

Figure 3 (Nalmefene 04)
This text provides information on the administration of medication, particularly Nalmefene, via intramuscular and intravenous routes. It also includes a table showing the mean Nalmefene plasma concentration (ng/mL) over time in hours. This data may be used for pharmacokinetic analysis of Nalmefene.*
FDA Label Image

Figure 4 (Nalmefene 05)

Figure 4 (Nalmefene 05)
This is a data table showing the mean (SD) Nalmefene plasma concentration in ng/mL for different drug administration routes and dosages. The concentrations are measured over time in minutes. The table includes data for ZURNAI 1.5 mg IM, Nalmefene 1.0 mg IM, and Nalmefene 1.0 mg IV administrations.*
FDA Label Image

Image (Nalmefene 06)

FDA Label Image

Image (Nalmefene 07)

FDA Label Image

Image (Nalmefene 08)

FDA Label Image

Image (Nalmefene 09)

FDA Label Image

Image (Nalmefene 10)

FDA Label Image

Image (Nalmefene 11)

FDA Label Image

Image (Nalmefene 12)

FDA Label Image

Image (Nalmefene 13)

FDA Label Image

Principal Display Panel (1.5 mg/0.5 mL Auto-Injector Label)

Principal Display Panel (1.5 mg/0.5 mL Auto-Injector Label)
This text seems to contain instructions for using a single-dose auto-injector for emergencies and storing it at room temperature. It also mentions discarding used sharps properly and provides details related to the product including lot number and expiry date. This information appears to be from a pharmaceutical company located in Stamford, CT.*
FDA Label Image

Principal Display Panel (1.5 mg/0.5 mL Auto-Injector Carton)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.